John Militello insider trades: Rocket Pharmaceuticals (RCKT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 19, 2026 | RCKT | ↓ Sell | 384 | $3.01 | $1K | Direct | May 21, 2026 (2d) |
| May 13, 2026 | RCKT | ↓ Sell | 855 | $3.61 | $3K | Direct | May 14, 2026 (1d) |
| Feb 18, 2026 | RCKT | ↓ Sell | 1,157 | $3.34 | $4K | Direct | Feb 20, 2026 (2d) |
| Feb 13, 2026 | RCKT | ↓ Sell | 3,726 | $3.31 | $12K | Direct | Feb 18, 2026 (5d) |
| Nov 18, 2025 | RCKT | ↓ Sell | 1,086 | $2.98 | $3K | Direct | Nov 20, 2025 (2d) |
| Oct 14, 2025 | RCKT | ↓ Sell | 28,918 | $3.96 | $115K | Direct | Oct 16, 2025 (2d) |
| Aug 19, 2025 | RCKT | ↓ Sell | 1,060 | $3.04 | $3K | Direct | Aug 20, 2025 (1d) |
| Aug 14, 2025 | RCKT | ↓ Sell | 7,043 | $3.02 | $21K | Direct | Aug 18, 2025 (4d) |
| May 20, 2025 | RCKT | ↓ Sell | 357 | $6.45 | $2K | Direct | May 22, 2025 (2d) |
| May 16, 2025 | RCKT | ↓ Sell | 655 | $6.53 | $4K | Direct | May 20, 2025 (4d) |
| Apr 22, 2025 | RCKT | ↓ Sell | 718 | $7.16 | $5K | Direct | Apr 24, 2025 (2d) |
| Feb 21, 2025 | RCKT | ↓ Sell | 2,737 | $10.58 | $29K | Direct | Feb 25, 2025 (4d) |
| Jan 23, 2025 | RCKT | ↓ Sell | 896 | $10.38 | $9K | Direct | Jan 27, 2025 (4d) |
| Nov 21, 2024 | RCKT | ↓ Sell | 1,224 | $13.05 | $16K | Direct | Nov 25, 2024 (4d) |
| Oct 31, 2024 | RCKT | ↓ Sell | 917 | $16.63 | $15K | Direct | Nov 4, 2024 (4d) |
| Aug 16, 2024 | RCKT | ↓ Sell | 1,064 | $18.50 | $20K | Direct | Aug 20, 2024 (4d) |
| Jul 22, 2024 | RCKT | ↓ Sell | 812 | $23.02 | $19K | Direct | Jul 24, 2024 (2d) |
| May 16, 2024 | RCKT | ↓ Sell | 1,079 | $23.35 | $25K | Direct | May 20, 2024 (4d) |
| Apr 22, 2024 | RCKT | ↓ Sell | 833 | $22.87 | $19K | Direct | Apr 24, 2024 (2d) |
| Mar 21, 2024 | RCKT | ↓ Sell | 2,490 | $28.10 | $70K | Direct | Mar 25, 2024 (4d) |
| Feb 29, 2024 | RCKT | ↓ Sell | 10,000 | $29.84 | $298K | Direct | Mar 4, 2024 (4d) |
| Feb 16, 2024 | RCKT | ↓ Sell | 3,238 | $29.84 | $97K | Direct | Feb 21, 2024 (5d) |
| Jan 22, 2024 | RCKT | ↓ Sell | 638 | $27.20 | $17K | Direct | Jan 23, 2024 (1d) |
| Oct 20, 2023 | RCKT | ↓ Sell | 564 | $17.06 | $10K | Direct | Oct 25, 2023 (5d) |
| Aug 17, 2023 | RCKT | ↓ Sell | 284 | $15.47 | $4K | Direct | Aug 21, 2023 (4d) |
| Jul 20, 2023 | RCKT | ↓ Sell | 573 | $19.03 | $11K | Direct | Jul 24, 2023 (4d) |
| May 17, 2023 | RCKT | ↓ Sell | 245 | $21.38 | $5K | Direct | May 19, 2023 (2d) |
| Apr 21, 2023 | RCKT | ↓ Sell | 2,342 | $18.65 | $44K | Direct | Apr 25, 2023 (4d) |
| Feb 17, 2023 | RCKT | ↓ Sell | 1,244 | $19.06 | $24K | Direct | Feb 22, 2023 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCKT insiders
Open-market trades in the last 12 months
About John Militello's insider trades
John Militello is See Remarks at Rocket Pharmaceuticals (RCKT). Since Feb 17, 2023, John has reported no open-market purchases and 29 sales worth $907K on SEC Form 4. In the last 12 months: 5 sales ($24K).
Their filings also include grants and awards (16 filings), option exercises (8 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.